Home / News / CMS Belgium and CMS France advised Biogroup in connection...

CMS Belgium and CMS France advised Biogroup in connection with the acquisition of CMA-Medina

19/11/2020

CMS Belgium and CMS France advised Biogroup in connection with the acquisition of the Belgian clinical lab Group CMA-Medina. With this acquisition, the largest private clinical blood analysis groups in France and Belgium are joining forces. 

CMS acted as legal and tax advisor, alongside investment bank Degroof Petercam and financial advisors EY and KPMG.

The CMS team advising Biogroup in Belgium was lead by Arnaud Van Oekel and comprised David Prync, Candice Kunkera and Lola Verelst for the Corporate/M&A aspects, Bruno Fonteyn (regulatory), Sophie Berg (HR) and Olivier Querinjean and his team for the tax aspects.

The CMS France team comprised Christophe Blondeau, Benoit Gomel, Célia Mayran, Noëlle Boualem and Marion Bladé for the Corporate/M&A aspects and Jean-Charles Benois, Alexia Cayrel, Vincent Forestier and Thomas Louvel for the tax aspects.

Related people

Picture of Arnaud Van Oekel
Arnaud Van Oekel
Partner
Brussels
Picture of David Prync
David Prync
Senior Associate
Brussels
Candice Kunkera
Candice Kunkera
Associate
Brussels
Lola Verelst
Junior Associate
Brussels
Picture of Bruno Fonteyn
Bruno Fonteyn
Senior Associate
Brussels
Picture of Sophie Berg
Sophie Berg
Partner
Brussels
Picture of Olivier Querinjean
Olivier Querinjean
Partner
Brussels
Show more Show less